---
schema_version: "secwatch.filing_event.v1"
accession: "0001140361-23-029970"
form_type: "8-K"
ticker: "FEMY"
cik: "0001339005"
company_name: "FEMASYS INC"
filed_at: "2023-06-15T23:59:59+00:00"
generated_at: "2026-06-13T23:53:51.960885+00:00"
event_type: "leadership"
sentiment: "neutral"
materiality_score: 0.55
calibrated_materiality_score: 0.55
confidence: "high"
source: SEC EDGAR
---

# Femasys appoints Kendall and Milnes to board, replacing Dyett and Adams

## Summary
- John Dyett and John Adams resigned from board effective June 14, 2023; no disagreement with company.
- Keith Kendall (former CEO/President/CFO of Aquestive Therapeutics) appointed Class III director and Audit Committee Chair.
- Alistair Milnes (COO of Bicycle Therapeutics) appointed Class I director, serves on Audit and Nominating Committees.
- Anne Morrisey resigned from Audit Committee effective June 14, 2023.
- New directors entitled to standard annual retainer and equity awards under company policy.

## SEC filing metadata
- accession: 0001140361-23-029970
- form_type: 8-K
- ticker: FEMY
- cik: 0001339005
- company_name: FEMASYS INC
- filed_at: 2023-06-15T23:59:59+00:00
- event_type: leadership
- sentiment: neutral
- materiality_score: 0.55
- calibrated_materiality_score: 0.55
- confidence: high
- sec_items: 5.02, 8.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1339005/000114036123029970/0001140361-23-029970-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1339005/000114036123029970/brhc20054453_8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001140361-23-029970
- JSON: https://secwatch.observer/filing/0001140361-23-029970.json
- Plain text: https://secwatch.observer/filing/0001140361-23-029970.txt

## Key facts
- Executive change
  John Dyett resigned as Director at FEMASYS INC.
  - Action: resigned
  - Role: Director
  source text: Effective June 14, 2023, the Board of Directors of Femasys Inc. (the “Company”) accepted John Dyett and John Adams’s resignation from the Board of Directors.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1339005/000114036123029970/0001140361-23-029970-index.htm
- Executive change
  Alistair Milnes was appointed as Director at FEMASYS INC.
  - Action: appointed
  - Role: Director
  source text: In connection with Messrs. Dyett and Adams’s resignations, the Board of Directors appointed Keith J. Kendall and Alistair Milnes as directors of the Company.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1339005/000114036123029970/0001140361-23-029970-index.htm
- Executive change
  Keith J. Kendall was appointed as Director at FEMASYS INC.
  - Action: appointed
  - Role: Director
  source text: In connection with Messrs. Dyett and Adams’s resignations, the Board of Directors appointed Keith J. Kendall and Alistair Milnes as directors of the Company.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1339005/000114036123029970/0001140361-23-029970-index.htm
- Executive change
  John Adams resigned as Director at FEMASYS INC.
  - Action: resigned
  - Role: Director
  source text: Effective June 14, 2023, the Board of Directors of Femasys Inc. (the “Company”) accepted John Dyett and John Adams’s resignation from the Board of Directors.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1339005/000114036123029970/0001140361-23-029970-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.